522 results
Page 5 of 27
8-K
EX-10.1
a4vfie
31 Aug 20
Entry into a Material Definitive Agreement
5:10pm
424B5
dkhuhu
22 Jul 20
Prospectus supplement for primary offering
4:33pm
424B5
us7djw
14 Jul 20
Prospectus supplement for primary offering
4:59pm
424B5
vlrix
2 Jul 20
Prospectus supplement for primary offering
4:30pm
424B5
i630v 8bh3
3 Jun 20
Prospectus supplement for primary offering
10:12am
8-K
EX-4.1
dlkbssu
3 Jun 20
ARCA Biopharma announces CLOSING OF $6.1 million registered
9:44am
8-K
EX-10.1
n3ovsibe 16
3 Jun 20
ARCA Biopharma announces CLOSING OF $6.1 million registered
9:44am
8-K
EX-99.2
un92f1d
3 Jun 20
ARCA Biopharma announces CLOSING OF $6.1 million registered
9:44am
8-K
EX-99.1
h4891htkms kkx8hee
28 May 20
ARCA Biopharma announces AB201 development program for treatment of covid-19 ASSOCIATED COAGulopAthy
5:15pm
UPLOAD
ebnh14ys5c4k
14 May 20
Letter from SEC
12:00am